We are live on
!
Find out more
Acadia Pharmaceuticals
ACAD
ACAD
186 hedge funds and large institutions have $2.25B invested in Acadia Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 63 increasing their positions, 56 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
13% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 56
12% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 33
2% more funds holding
Funds holding: 183 → 186 (+3)
1.22% more ownership
Funds ownership: 96.01% → 97.22% (+1.2%)
5% more call options, than puts
Call options by funds: $27.1M | Put options by funds: $25.7M
9% less capital invested
Capital invested by funds: $2.49B → $2.25B (-$236M)
Holders
186
Holders Change
+3
Holders Change %
+1.64%
% of All Funds
4.14%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
37
Increased
63
Reduced
56
Closed
33
Calls
$27.1M
Puts
$25.7M
Net Calls
+$1.38M
Net Calls Change
-$16.5M
Top Buyers
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$219M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$71.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$54.2M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$30.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25.5M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$38.8M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$33.6M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$22.9M |
| 4 |
PP
PDT Partners
New York
|
-$10.6M |
| 5 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$9.08M |
